ACB — AURORA CANNABIS INC
—
Nasdaq ·
Materials ·
Chemicals ·
CIK 1683541 ·
Last close
$4.49
Market Cap
$284.26M
52W High
$6.36
52W Low
$2.56
ADV30
1,063,578
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 67,554,000 | 35,622,000 | -8,731,000 | -4,033,000 | 620,877,000 | 69,307,000 | 93,746,000 |
| Mar 2026 | 38,013,000 | 29,788,000 | -10,030,000 | -71,101,000 | 601,087,000 | 64,690,000 | 89,255,000 |
| Dec 2025 | 94,191,000 | 46,620,000 | 2,184,000 | 1,820,000 | 775,292,000 | 56,363,000 | 207,466,000 |
| Sep 2025 | 90,366,000 | 32,291,000 | -18,273,000 | -51,474,000 | 756,863,000 | 95,689,000 | 189,763,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,828,000
Investing CF
$-72,844,000
Financing CF
$4,896,000
CapEx
$-22,545,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.64
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,445,941,000
Inventory
$187,543,000
Receivables
$41,091,000
ST Investments
$30,722,000
EBIT TTM
$-40,272,000
Pretax Income TTM
$-40,770,000
Interest Exp TTM
$498,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$314,071,008
EBITDA
$-29,952,000
Free Cash Flow
$-20,040,750
Enterprise Value
$165,238,208
Total Cash
$100,029,000
Total Debt
$22,684,000
Shares Out
63,310,061
Trailing EPS
$-0.67
Book Value
$6.01
ROE
-9.4%
ROA
-3.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 320,593,000 | -46,662,000 | -135,964,000 | 601,087,000 | 89,255,000 | 511,832,000 | -13,511,000 |
| Mar 2025 | 288,911,000 | 10,434,000 | 1,591,000 | 852,666,000 | 244,075,000 | 567,171,000 | 16,006,000 |
| Mar 2024 | 269,637,000 | -31,053,000 | -69,326,000 | 838,673,000 | 236,803,000 | 559,773,000 | -68,508,000 |
| Jun 2022 | 221,339,000 | -219,375,000 | -1,717,624,000 | 1,084,356,000 | 422,002,000 | 661,843,000 | -110,267,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.11
Max Pain — expiry 2026-12-18
max pain strike: $3.00 · spot: $4.49 · call oi: 6,032 · put oi: 2,238
Expected Move to 2026-12-18:
±$1.12
(25.06%) —
implied range
$3.36 –
$5.61
· ATM straddle on $4.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ALTO | Alto Ingredients, Inc. | $288.94M | $3.72 | — |
| USNA | USANA HEALTH SCIENCES INC | $270.87M | $14.66 | — |
| SNDL | SNDL Inc. | $300.27M | $1.22 | — |
| BAK | BRASKEM SA | $314.00M | $1.82 | — |
| OEC | Orion S.A. | $325.36M | $5.77 | — |
News headlines (Yahoo Finance, 1h cache)
Aurora Cannabis Heads 3 Canadian Healthcare Stocks To Watch
2026-10-10 03:16 · Yahoo
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
2026-10-08 11:05 · Yahoo
Curaleaf Holdings (TSX:CURA) Could Be 24% Undervalued After Its Raised Aurora Bid
2026-10-08 09:07 · Yahoo
Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
2026-10-06 15:55 · Yahoo
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
2026-10-05 22:11 · Yahoo
Curaleaf raises Aurora Cannabis offer by 25%
2026-10-05 13:05 · Yahoo
Curaleaf Enhances Offer to Acquire Aurora Cannabis
2026-10-05 12:00 · Yahoo
Curaleaf (TSX:CURA) Stock May Be A Bargain After Its Raised Takeover Offer
2026-10-08 04:29 · Yahoo
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
2026-10-06 20:30 · Yahoo
Curaleaf Files Update to Offering Circular
2026-10-06 15:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.